Webinar image
Webinar image
  • Blog Post

Webinar: New Medication Options in Behavioral Health

Oct 8th, 2021

Behavioral Health Drug Updates

This year the Federal Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a number of new drug therapies to treat behavioral health conditions, including new drugs for treating attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and more. What do behavioral health care providers need to know about these new medications?

Genoa Healthcare’s Vice President of Pharmacy Solutions Abbie Vogler, PharmD, recently hosted a webinar in which she addressed new behavioral drugs and their unique attributes. To learn more, watch the webinar, which:

  • Explores new behavioral health drugs approved in 2021
  • Reviews 2020 drug approvals and the recent pace of FDA approvals
  • Looks ahead to coming drug trends
  • Provides an update on COVID-19 vaccine developments

You can also read highlights from this webinar here and check out our FAQ here.

To learn more about how Genoa can help you and those you serve, contact us today.

Recent Posts


  • Pharmacy Openings
Announcing six new pharmacy openings!

We’re excited to announce the opening of six pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve...

  • Pharmacy Openings
Announcing seven new pharmacy openings!

We’re excited to announce the opening of seven pharmacies last month. We welcome all new pharmacy staff to the team and are excited to partner with these organizations to serve their...

  • Blog Post
Genoa Healthcare® Pharmacists’ Trusting Consumer Relationships Aid in Support for Long-Acting Injectable Treatments

Providing Support for Long-Acting Injectable Treatments When a consumer who had recently been discharged from the hospital came into their Genoa pharmacy to receive a long-acting injectable (LAI) treatment for...

  • News Releases
New medication options in behavioral health

FDA Approves 14 New Medications The FDA has approved 14 new medication and treatment options for the behavioral health space to date in 2022. The new medication and treatment options...